SAN DIEGO, CA, UNITED STATES, April 30, 2026 /EINPresswire.com/ — Leveraging 35+ Years of Expertise to Guide Innovation from Development Through Global Approval Gayle Freudinger is a seasoned ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...

Spread the loveThe pharmaceutical industry is currently a dynamic and rapidly evolving sector, marked by significant advancements and challenges. As we progress through 2026, several notable trends ...

Dr. Maki brings nearly 20 years of biotechnology and pharma business development expertise as Company rapidly advances its powerful LNP platform to deliver mRNA-based therapies MENLO PARK, Calif. & ...

The "The Pharma Mini MBA (July 8th - July 10th, 2026)" has been added to ResearchAndMarkets.com's offering. The Pharma Mini MBA is a unique, three-day virtual management program tailor-made for ...

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc.

Drug approvals depend on frameworks invisible to patients but essential to survival. Behind every approved therapy lies a complex compliance and governance infrastructure that determines whether ...

At Bayer, a groupwide restructuring is being rolled out as a top priority. But, to Juergen Eckhardt, M.D., who leads both the investment arm Leaps by Bayer and the pharma business development team, ...

Apr 27, 2026--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that th ...